Canadian innovation builds a brighter tomorrow.

ViewsML

AIBiotechnology & Life SciencesVancouver, BC

Vancouver company, registered as ViewsML Technologies Inc., training deep-learning models that predict biomarker staining from routine pathology slides instead of running physical immunohistochemistry.

Visit Website LinkedIn Careers

The Toronto skyline and the CN Tower at sunset, seen across Lake Ontario.

Canadian innovation builds a brighter tomorrow.

About

Company site: viewsml.com

States it uses "deep learning to eliminate physical staining", returning virtual results in seconds at a fraction of the cost of conventional immunohistochemistry. viewsml.com
BC corporation BC1356518, registered as ViewsML Technologies Inc. on 2022-04-04, entity status Active. orgbook.gov.bc.ca
Closed an oversubscribed US$4.9M seed round led by Wittington Ventures, announced April 2026. natlawreview.com
Building what it calls the world's first virtual biomarker library, an expanding platform of AI models drawing insights from routine pathology images. natlawreview.com
Mayo Clinic and Continuum Health Ventures joined as new investors in the 2026 seed round. techcouver.com

Funding & Investors

Announced rounds only, newest first. Undisclosed amounts are shown as undisclosed.

Seed
Apr 20, 2026
US$4.9Mnatlawreview.com
Investors: Wittington Ventures, Continuum Health Ventures, Mayo Clinic, RiSC Capital, Debiopharm, WUTIF Capital

Total disclosed: US$4.9MLatest: Seed · Apr 20, 2026

Recent News

Apr 20, 2026Funding
ViewsML secures funding to accelerate commercialization of AI-driven virtual biomarkers
ViewsML closed an oversubscribed US$4.9M seed round led by Wittington Ventures, with Continuum Health Ventures and Mayo Clinic joining as new investors. The company is building a virtual biomarker library of AI models that extract insights from routine pathology images.
natlawreview.com